ChemicalBook
English   Japanese   Germany   Korea

(2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯

(2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯, 923604-57-3, 结构式
(2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯
CAS号:
923604-57-3
英文名:
siMeprevir interMediate
英文别名:
CB-1004;siMeprevir interMediate;Simeprevir cyclized intermediate;(2R,3aR,10Z,11aS,12aR,14aR)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-Tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxylic acid ethyl ester;Cyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxylic acid, 2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxo-, ethyl ester, (2R,3aR,10Z,11aS,12aR,14aR)-
中文名:
(2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯
中文别名:
(2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯;(2R,3AR,10Z,11AS,12AR,14AR)-2,3,3A,4,5,6,7,8,9,11A,12,13,14,14A-十四氢-2-[[7-甲氧基-8-甲基-2-[4-异丙基-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊二烯并[C]环丙烯并[G][1,6]二氮杂环十四碳七烯-12A(1H)-羧酸乙酯
CBNumber:
CB92710867
分子式:
C37H46N4O6S
分子量:
674.85
MOL File:
923604-57-3.mol

(2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯化学性质

密度:
1?+-.0.06 g/cm3(Predicted)
蒸气压:
0-0Pa at 20-25℃
形态:
Solid:particulate/powder
酸度系数(pKa):
13.24±0.60(Predicted)
LogP:
6.7-7.6 at pH2-9
安全信息

(2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯性质、用途与生产工艺

(2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯 上下游产品信息

上游原料

下游产品


(2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯 生产厂家

供应商联系电话电子邮件国家产品数优势度
南京欣丰康生物科技有限公司 025-84683399 13952017251 sinfachem@foxmail.com 中国 268 58
AFINE CHEMICALS LIMITED +86-0571-85134551 info@afinechem.com 中国 15394 58
常州博嘉生物医药科技有限公司 2122619822 czbjpharma@126.com 中国 18488 58
湖北万业众诚化学试剂有限责任公司 18671296875 1205035102@qq.com 中国 4302 58
 

923604-57-3, (2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯 相关搜索:

  • 医药中间体
  • C37H46N4O6S
  • (2R,3AR,10Z,11AS,12AR,14AR)-2,3,3A,4,5,6,7,8,9,11A,12,13,14,14A-十四氢-2-[[7-甲氧基-8-甲基-2-[4-异丙基-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊二烯并[C]环丙烯并[G][1,6]二氮杂环十四碳七烯-12A(1H)-羧酸乙酯
  • (2R,3AR,11AS,12AR,14AR,Z)-2-(2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基-4-喹啉氧基)-5-甲基-4,14-二氧-1,2,3,3A,4,5,6,7,8,9,11A,12,12A,13,14,14A-16氢环戊烷并[C]环丙基并[G][1,6]双氮杂十四烷-12A-羧酸乙酯
  • 923604-57-3
  • CB-1004
  • Cyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxylic acid, 2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxo-, ethyl ester, (2R,3aR,10Z,11aS,12aR,14aR)-
  • Simeprevir cyclized intermediate
  • (2R,3aR,10Z,11aS,12aR,14aR)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-Tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxylic acid ethyl ester
  • siMeprevir interMediate
Copyright 2016 © ChemicalBook. All rights reserved